Cagrilintide

Cagrilintide (also referenced in the literature as AM833) is a synthetic amylin analogue supplied as a lyophilized powder for laboratory research use. Verified by High-Performance Liquid Chromatography (HPLC) to a purity of ≥ 99%, it offers the consistency and traceability expected of a premium biochemical reference compound.

Research background

Cagrilintide has been investigated as an amylin receptor agonist in in vitro and preclinical research models. The compound has been studied in the context of energy homeostasis, satiety signalling, and glucose-related metabolic pathways. It is referenced in the literature as a relevant tool for fundamental endocrinological research, particularly in studies examining the interplay between amylin receptor activity and broader metabolic regulation. Cagrilintide has also attracted interest in combination research settings alongside GLP-1 receptor agonists, where it is investigated as part of dual-mechanism metabolic signalling models.

Reconstitution & handling

Cagrilintide is supplied as a lyophilized powder and should be reconstituted with an appropriate volume of bacteriostatic water (BAC water) prior to use. Add the BAC water slowly to the vial, then gently swirl — do not shake — until the powder is fully dissolved. The reconstituted solution should be kept cold at all times and handled under appropriate aseptic laboratory conditions.

Storage & stability

• Store the lyophilized product refrigerated and protected from light.
• Avoid repeated freeze–thaw cycles to preserve peptide integrity.
• Once reconstituted, keep the solution refrigerated and use within a short, defined window consistent with standard peptide handling practice.

A batch-specific Certificate of Analysis (CoA) accompanies every order, confirming purity and identity data for the supplied material.